Creatine gummies aren't a niche novelty anymore. Create Wellness just closed a $20M Series B to push their creatine gummy line into national retail — and the funding signals something bigger about where the supplement market is heading.
The brand has sold 250 million gummies since launching in 2022. They're now stocked at Target, The Vitamin Shoppe, and Sprouts. Alliance Consumer Growth and Impact Capital co-led the round. And their next move goes well beyond creatine.
Key Takeaways
- $20M Series B closed March 30, 2026 to fund retail expansion and product innovation
- 250 million gummies sold since 2022 launch by Dan and Sienna McCormick
- National retail confirmed: Target, The Vitamin Shoppe, Sprouts
- New product: Creatine + Electrolytes (5g creatine, full electrolyte profile, 1g taurine)
- "Creatine gummies" sees 91,000 monthly US searches with keyword difficulty of 1 — demand is there, market isn't saturated yet
Why the Format Change Matters More Than the Formula
Creatine monohydrate is the most studied sports supplement in history. Hundreds of clinical trials confirm its impact on strength, muscle mass, and recovery. But for decades, it stayed a bodybuilder staple — because of the powder format, the taste, and the daily friction of mixing shakes.
Gummies remove that friction. No shaker, no measuring, nothing to mix. You take them like a multivitamin. That shift in delivery format opened the door to consumers traditional creatine couldn't reach: busy professionals, women, people over 40 who don't identify as athletes but want the benefits. That's the market Create Wellness unlocked — and it's what investors are backing.
What the Series B Tells You About the Market
Alliance Consumer Growth backs CPG brands in transition from niche to mainstream. Impact Capital follows the same playbook. When both lead a round, that's a signal: they don't fund niche products, they fund categories that are about to tip.
Creatine gummies were a bet in 2022. In 2026, they're a category. Evidence: 91,000 monthly US searches for "creatine gummies," with a keyword difficulty of 1 out of 100. The demand is real, but the editorial and retail landscape hasn't caught up yet. That gap is the opportunity — and it mirrors the broader dynamic playing out across creatine's projected path to a $4.2B market by 2030.
Creatine + Electrolytes: Where the Brand Is Going
The new product launched alongside the funding — Creatine + Electrolytes — shows the strategic direction clearly. The formula combines 5g creatine monohydrate with a balanced electrolyte profile (sodium, potassium, magnesium) and 1g of taurine for cognitive support and hydration.
It's a smart move on two levels. First, it targets use-case stacking: athletes who already take creatine can replace their hydration drink with this multi-purpose format. Second, it preemptively answers the main objection from non-athletes — "creatine makes you bloated" — by repositioning the product around energy and cognitive performance, not just muscle mass.
Three Signals for Brands and Investors
For anyone watching the supplement and fitness market, this funding sends three clear signals.
Format beats formula in new consumer purchase decisions. Creatine hasn't changed — its delivery has. Brands not thinking in format terms in 2026 are ceding ground to those who are.
Creatine's democratization continues. Target placement reaches a different consumer than sports pharmacies or DTC. That's market expansion, not cannibalization — a pattern visible across the broader protein and supplement market's push into mainstream retail.
Multi-benefit combinations will dominate. Creatine + Electrolytes signals a broader trend: consumers want products that do several things at once, without stacking five separate supplements.
Create Wellness didn't reinvent creatine. They reinvented how people buy and take it. That's usually where market wins actually happen.